These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 39111965)

  • 21. New perspectives on 'Breathomics': metabolomic profiling of non-volatile organic compounds in exhaled breath using DI-FT-ICR-MS.
    Malik M; Demetrowitsch T; Schwarz K; Kunze T
    Commun Biol; 2024 Mar; 7(1):258. PubMed ID: 38431745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exhaled breath testing - A tool for the clinician and researcher.
    Davis MD; Fowler SJ; Montpetit AJ
    Paediatr Respir Rev; 2019 Feb; 29():37-41. PubMed ID: 29921519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breath Biomarkers in Diagnostic Applications.
    Pham YL; Beauchamp J
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Advances in Sensing Materials Targeting Clinical Volatile Organic Compound (VOC) Biomarkers: A Review.
    Pathak AK; Swargiary K; Kongsawang N; Jitpratak P; Ajchareeyasoontorn N; Udomkittivorakul J; Viphavakit C
    Biosensors (Basel); 2023 Jan; 13(1):. PubMed ID: 36671949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exhaled VOC detection in lung cancer screening: a comprehensive meta-analysis.
    Fan X; Zhong R; Liang H; Zhong Q; Huang H; He J; Chen Y; Wang Z; Xie S; Jiang Y; Lin Y; Chen S; Liang W; He J
    BMC Cancer; 2024 Jun; 24(1):775. PubMed ID: 38937687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volatile organic compounds (VOCs) in exhaled breath as a marker of hypoxia in multiple chemical sensitivity.
    Mazzatenta A; Pokorski M; Di Giulio C
    Physiol Rep; 2021 Sep; 9(18):e15034. PubMed ID: 34536058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactate in exhaled breath condensate and its correlation to cancer: challenges, promises and a call for data.
    Ruzsányi V; Kalapos MP
    J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37433292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: research protocol for an exploratory study.
    Li W; Dai W; Liu M; Long Y; Wang C; Xie S; Liu Y; Zhang Y; Shi Q; Peng X; Liu Y; Li Q; Duan Y
    BMJ Open; 2019 Aug; 9(8):e028448. PubMed ID: 31399453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
    De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
    J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breath Testing in the Surgical Setting: Applications, Challenges, and Future Perspectives.
    Walsh CM; Fadel MG; Jamel SH; Hanna GB
    Eur Surg Res; 2023; 64(3):315-322. PubMed ID: 37311421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors that influence the volatile organic compound content in human breath.
    Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
    J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
    Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
    J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.
    Amann A; Costello Bde L; Miekisch W; Schubert J; Buszewski B; Pleil J; Ratcliffe N; Risby T
    J Breath Res; 2014 Sep; 8(3):034001. PubMed ID: 24946087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exhaled breath analysis using on-line preconcentration mass spectrometry for gastric cancer diagnosis.
    Hong Y; Che X; Su H; Mai Z; Huang Z; Huang W; Chen W; Liu S; Gao W; Zhou Z; Tan G; Li X
    J Mass Spectrom; 2021 Apr; 56(4):e4588. PubMed ID: 32633879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling-based determination of physiological parameters of systemic VOCs by breath gas analysis, part 2.
    Ager C; Unterkofler K; Mochalski P; Teschl S; Teschl G; Mayhew CA; King J
    J Breath Res; 2018 Apr; 12(3):036011. PubMed ID: 29488464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Driving progress in exhaled breath biomarkers: Breath Biopsy Conference 2019.
    Lawson J; Boyle B; Beauchamp J
    J Breath Res; 2020 Jul; 14(3):030202. PubMed ID: 32662449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.